- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03863340
Short Interventions to Prevent Trapezius Muscle Fatigue in Computer Work
Trapezius Muscle Fatigue of Long Duration: a Likely Neuromuscular Control Issue
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
30 healthy adults without chronic neck pain participated in a laboratory study designed to simulate two full workdays of computer work. Within each session, participants performed five 50-min working activities separated by 10-min breaks: i) Use a computer keyboard to type a text presented on the left side of the screen; ii) do the typing task with the desk height set10 cm above elbow height; iii) play the computer game Spider Solitaire implemented in Windows 10; iv) Stroop test (This test consists of reading the name of a color whose text is in a color different from the name. The color name was then selected from a multiple-choice panel displaying color names; v) the same online puzzle game was presented to all participants. Assembling the puzzle was performed by drag and drop actions. The work periods were not disrupted (on the "control day") whereas two short interruptions of 5-min were introduced at 1/3 and 2/3 of each working period on the "intervention day". During these interruptions, participants were asked to perform "muscle disrupting/relaxing" activities. For each experimental session a 30-min lunch break took place between the third and the fourth work periods. The specific sequence of work activity type and disrupting/relaxing activities was randomized across participants; however, for each participant the order of work activities remained the same for the two experimental sessions (control and intervention days). The order of control and intervention days was also randomized between participants.
A set of six measures were performed at specific time intervals during each experiment: before the first work activity, before and after lunch, immediately and 1 hour after the fifth (last) work activity: i) upper trapezius activation, assessed through the temporal EMG profile recorded by a single bipolar signal; and ii) through the spatio-temporal distribution of EMG activity detected by a 2D array of electrodes (64 channels); iii) muscle fatigue, quantified by changes in electrically induced muscle twitch force signals, iv) isometric performance, v) dynamic performance; iii) cognitive and physical load and stress level. In addition, personality traits (anxiety level), perceived workload and musculoskeletal symptoms were evaluated as covariates.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- healthy experienced computer workers
Exclusion Criteria:
- chronic pain (more than 30 days within the last 12 months according to the Nordic Questionnaire (Kuorinka et al 1987);
- pathologies of the neck,
- prior and actual shoulder or neck pain caused by an accident,
- skin disease in the neck or shoulder area,
- BMI > 30,
- sleep disorders (e.g. apnea, restless legs syndrome),
- use of medications such as psychotropic drugs, muscle relaxants or analgesics within the last 3 days prior to the experiment,
- pregnancy.
- any shoulder/neck pain on the day before the experiment.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Interventionsmodell: Sequenzielle Zuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: short interruptions of work tasks
randomly start with or without short interruptions on the first experimental day and without or with them on the second experimental day
|
During each activity two interruptions/breaks were selected randomly from a set of ten predetermined actions: Active break types:
Passive break types:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
EMG profile recorded by a single bipolar electrode: Rest-time
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
Rest-time (percentage of time below 5% of the standard activity level).
The percentage of registration time without any rest time is called sustained low level muscle activity.
|
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
|
Spatio-temporal distribution of EMG activity: Area of muscle activity
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Area of muscle active region (n. of channels) |
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
|
Muscle fatigue: Change of muscle twitch
Zeitfenster: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
3-D muscle twitch acceleration pattern measured at the acromion
|
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
|
Muscle fatigue: Change of dynamic force control accuracy
Zeitfenster: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in an isometric dynamic tracking task
|
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
EMG profile recorded by a single bipolar electrode: Static activity
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
p10 (level of the 10th percentile of the trapezius muscle activity) as an indicator of static activity primarily associated with continuous activity of the same pool of motor units.
|
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
|
Spatio-temporal distribution of EMG activity: Magnitude of activity
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Magnitude of activity of muscle active regions (RMS sEMG). |
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
|
Spatio-temporal distribution of EMG activity: Number of active epochs
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Number of active epochs
|
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
|
Muscle fatigue: Change of static force control
Zeitfenster: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric isotonic low level contraction
|
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
|
Muscle fatigue: Change of force control in ramp contraction
Zeitfenster: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric ramp contraction.
|
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Localized musculoskeletal discomfort
Zeitfenster: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
|
head-neck-shoulders-lower back-elbows-wrists-hip-upper legs-knees-ankles-feet-discomfort rated on 10 cm visual analog scales (adapted from Nordic questionnaire (Kuorinka et al 1987)
|
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
|
|
Visual and general fatigue
Zeitfenster: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
|
10 cm visual analog scales
|
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
|
|
Effort
Zeitfenster: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
|
6-20 Borg scale (6= no effort, 20=maximal possible effort)
|
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
|
|
EMG profile recorded by a single bipolar electrode: Dynamic activity
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
p90 (level of the 90th percentile of the trapezius muscle activity) as an indicator of dynamic activity which may promote variability in the recruitment of motor units
|
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
|
Spatio-temporal distribution of EMG activity: Centroid of active regions
Zeitfenster: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Centroid of active regions
|
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Thomas Läubli, MD, Federal Institute of Technology Zurich
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 32003B_160207
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .